Amarin Shares Skyrocketed: What You Need to Know

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of biopharmaceutical company Amarin (Nasdaq: AMRN  ) surged a staggering 80% today on positive results for its fish oil heart disease treatment.

So what: In a late-stage clinical trial, Amarin's lead product candidate, AMR101, was effective at reducing triglycerides without increasing LDL cholesterol, or "bad cholesterol," after 12 weeks. Lovaza -- GlaxoSmithKline's (NYSE: GSK  ) triglyceride drug which can raise LDL levels in some patients -- managed to bring in $900 million worth of sales last year, so it's no surprise that Mr. Market is extremely excited about AMR101's potential.

Now what: Amarin seems like an interesting situation for speculative investors. AMR101 continues to display clear benefits over competing triglyceride drugs, making it an increasingly tempting takeover target. It's hard to believe, but even with today's 80%-plus surge, Amarin might still be a steal for a patent cliff-facing drug giant.  

Interested in more info on Amarin? Add it to your watchlist.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Glaxo is a Motley Fool Global Gains selection, and the Fool owns shares of it. Try any of our Foolish newsletter services free for 30 days.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 1477128, ~/Articles/ArticleHandler.aspx, 4/24/2014 7:44:31 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement